Allianz Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.9M | Buy |
49,500
+2,200
| +5% | +$308K | 0.01% | 1022 |
|
|
2025
Q4 | $5.81M | Buy |
47,300
+4,900
| +12% | +$595K | 0.01% | 1066 |
|
|
2025
Q3 | $4.71M | Sell |
42,400
-8,500
| -17% | -$966K | 0.01% | 1141 |
|
|
2025
Q2 | $5.64M | Buy |
50,900
+3,100
| +6% | +$330K | 0.01% | 1048 |
|
|
2025
Q1 | $5.36M | Sell |
47,800
-18,900
| -28% | -$1.95M | 0.01% | 1069 |
|
|
2024
Q4 | $6.16M | Sell |
66,700
-9,300
| -12% | -$837K | 0.01% | 945 |
|
|
2024
Q3 | $6.37M | Buy |
76,000
+12,800
| +20% | +$977K | 0.01% | 917 |
|
|
2024
Q2 | $4.34M | Buy |
63,200
+51,400
| +436% | +$3.43M | 0.01% | 1033 |
|
|
2024
Q1 | $864K | Sell |
11,800
-23,200
| -66% | -$1.78M | ﹤0.01% | 1458 |
|
|
2023
Q4 | $2.84M | Sell |
35,000
-49,400
| -59% | -$3.84M | ﹤0.01% | 1178 |
|
|
2023
Q3 | $6.32M | Buy |
84,400
+5,000
| +6% | +$385K | 0.01% | 899 |
|
|
2023
Q2 | $6.12M | Buy |
79,400
+6,700
| +9% | +$534K | 0.01% | 793 |
|
|
2023
Q1 | $6.03M | Buy |
72,700
+21,600
| +42% | +$1.79M | 0.01% | 900 |
|
|
2022
Q4 | $4.39M | Buy |
51,100
+4,300
| +9% | +$341K | 0.01% | 973 |
|
|
2022
Q3 | $2.89M | Buy |
46,800
+34,100
| +269% | +$2.15M | 0.01% | 1107 |
|
|
2022
Q2 | $785K | Sell |
12,700
-25,700
| -67% | -$1.59M | ﹤0.01% | 1758 |
|
|
2022
Q1 | $2.28M | Buy |
38,400
+25,300
| +193% | +$1.62M | ﹤0.01% | 1550 |
|
|
2021
Q4 | $951K | Sell |
13,100
-57,800
| -82% | -$3.98M | ﹤0.01% | 1933 |
|
|
2021
Q3 | $4.95M | Buy |
70,900
+55,700
| +366% | +$3.91M | ﹤0.01% | 1282 |
|
|
2021
Q2 | $1.05M | Buy |
+15,200
| New | +$1.01M | ﹤0.01% | 1724 |
|
|
2020
Q3 | – | Sell |
-115,300
| Closed | -$8.87M | – | 2065 |
|
|
2020
Q2 | $8.87M | Buy |
115,300
+12,900
| +13% | +$989K | 0.01% | 944 |
|
|
2020
Q1 | $7.66M | Sell |
102,400
-60,400
| -37% | -$4.17M | 0.01% | 970 |
|
|
2019
Q4 | $10.6M | Sell |
162,800
-12,500
| -7% | -$814K | 0.01% | 1107 |
|
|
2019
Q3 | $11.1M | Buy |
175,300
+6,900
| +4% | +$451K | 0.01% | 1054 |
|
|
2019
Q2 | $11.4M | Buy |
168,400
+67,700
| +67% | +$4.45M | 0.01% | 1129 |
|
|
2019
Q1 | $6.55M | Buy |
100,700
+62,600
| +164% | +$4.16M | 0.01% | 1333 |
|
|
2018
Q4 | $2.38M | Sell |
38,100
-51,500
| -57% | -$3.6M | ﹤0.01% | 1695 |
|
|
2018
Q3 | $6.92M | Sell |
89,600
-16,000
| -15% | -$1.21M | 0.01% | 1414 |
|
|
2018
Q2 | $7.48M | Buy |
105,600
+3,000
| +3% | +$212K | 0.01% | 1371 |
|
|
2018
Q1 | $7.74M | Sell |
102,600
-165,800
| -62% | -$13.2M | 0.01% | 1363 |
|
|
2017
Q4 | $19.2M | Buy |
268,400
+38,300
| +17% | +$2.91M | 0.02% | 990 |
|
|
2017
Q3 | $18.6M | Buy |
230,100
+87,100
| +61% | +$6.66M | 0.02% | 1001 |
|
|
2017
Q2 | $10.1M | Sell |
143,000
-14,400
| -9% | -$958K | 0.01% | 1302 |
|
|
2017
Q1 | $10.7M | Sell |
157,400
-243,700
| -61% | -$17.1M | 0.01% | 1304 |
|
|
2016
Q4 | $28.7M | Buy |
401,100
+114,000
| +40% | +$8.47M | 0.03% | 827 |
|
|
2016
Q3 | $22.7M | Buy |
287,100
+92,300
| +47% | +$7.5M | 0.02% | 896 |
|
|
2016
Q2 | $16.3M | Buy |
194,800
+136,700
| +235% | +$12.1M | 0.02% | 1015 |
|
|
2016
Q1 | $5.34M | Buy |
58,100
+1,400
| +2% | +$126K | 0.01% | 1416 |
|
|
2015
Q4 | $5.74M | Buy |
56,700
+25,000
| +79% | +$2.6M | 0.01% | 1296 |
|
|
2015
Q3 | $3.11M | Sell |
31,700
-38,000
| -55% | -$4.22M | ﹤0.01% | 1455 |
|
|
2015
Q2 | $8.16M | Buy |
69,700
+7,000
| +11% | +$765K | 0.01% | 1185 |
|
|
2015
Q1 | $6.15M | Buy |
62,700
+6,400
| +11% | +$650K | 0.01% | 1137 |
|
|
2014
Q4 | $5.31M | Buy |
56,300
+29,600
| +111% | +$3.06M | 0.01% | 1195 |
|
|
2014
Q3 | $2.84M | Buy |
+26,700
| New | +$2.61M | ﹤0.01% | 1304 |
|
Other funds holding GILD
VCM
VPM
Allianz Asset Management's GILD Position: Q1 2026 in Review
Allianz Asset Management reduced its Gilead Sciences (GILD) stake by 23% in Q1 2026, selling an estimated $131M and leaving 3,094,227 shares worth $431M. The position accounts for 0.45% of the portfolio, ranked #34.
Allianz Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $731M in Q2 2015. 2,312 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Allianz Asset Management held 3,094,227 shares of Gilead Sciences worth $431M as of Q1 2026.
- Allianz Asset Management sold 936,303 Gilead Sciences shares in Q1 2026, an estimated $131M.
- Gilead Sciences made up 0.45% of Allianz Asset Management's portfolio in Q1 2026, its #34 holding.
- Allianz Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Gilead Sciences position peaked at $731M in Q2 2015.
- 2,312 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.